Squamous Lung Cancer With FGFR1 Amplification
2 clinical trials · Condition
◉ Watch Squamous Lung Cancer With FGFR1 Amplification
| Record | Firm | Date |
|---|---|---|
| A Dose Escalation Study in Adult Patients With Advanced Solid Malignancies (NCT01004224) | Novartis Pharmaceuticals | 2009-12-11 |
Track Squamous Lung Cancer With FGFR1 Amplification automatically
Every clearance here is in the API, with alerts when new ones post.